All Stories

  1. Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
  2. SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes?
  3. Comprehensive study on human pancreatic β-cell regulatory mechanism
  4. Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited
  5. Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment
  6. Ten Tips for Healthy Longevity
  7. Pancreas Fat and β Cell Mass in Humans With and Without Diabetes: An Analysis in the Japanese Population
  8. Changing Our Concept of Type 2 Diabetes
  9. From Bench to Bedside as well as to “The Society”: An Open Discussion is Critical for Progress of Medicine
  10. Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas
  11. The pancreas in humans with and without diabetes
  12. Changing Our Mind: Beta Cell Workload Hypothesis
  13. Is There A New Therapeutic Strategy For Type 2 Diabetes? Beta Cell Workload Hypothesis
  14. Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
  15. A review of alogliptin, a DPP-4 inhibitor, for treatment of diabetes
  16. β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes
  17. Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?
  18. Importance of Beta Cell Function for the Treatment of Type 2 Diabetes
  19. Pancreas Volume With Obesity in Asians
  20. Obesity, Type 2 Diabetes and Beta Cell Failure: An Asian Perspective
  21. Maternally Inherited Diabetes and Deafness (MIDD) with Undetectable CPeptide Level and Cerebellar Atrophy
  22. Change in β-Cell Mass in Japanese Nondiabetic Obese Individuals
  23. Response to Comment on: Saisho et al. β-Cell Mass and Turnover in Humans: Effects of Obesity and Aging. Diabetes Care 2013;36:111–117
  24. Reply to Dr. Retnakaran